1-MONTH TREATMENT WITH ELUXADOLINE FOR IBS-D PREDICTS SUSTAINED RESPONSE: CONTINUATION ANALYSES OF RESPONSE IN TWO PHASE 3 STUDIES

William D. Chey  1     David A. Andrae  2     Leonard S. Dove  3     Catherine R. Gutman  2     Paul S. Covington  4    
1 University of Michigan, Ann Arbor, United States of America
2 Allergan plc, Jersey City, United States of America
3 Former employee of FuriePharmaceuticals, an Allergan affiliate, Jersey City, United States of America
4 Former employee of FuriePharmaceuticals, an Allergan affiliate, Jer

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing